$PDSB
PDS Biotechnology Corp

2023 Q1 Form 10-K Financial Statement

#000114036123014279 Filed on March 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.579M $2.666M $12.24M
YoY Change 7.86% -9.08% 20.19%
% of Gross Profit
Research & Development $5.844M $16.16M $29.43M
YoY Change 13.22% 376.65% 161.5%
% of Gross Profit
Depreciation & Amortization $3.155K $11.58K $86.00
YoY Change 3405.56% 1118.95% -98.39%
% of Gross Profit
Operating Expenses $9.422M $18.82M $41.67M
YoY Change 11.12% 197.73% 94.37%
Operating Profit -$9.422M -$41.67M
YoY Change 11.12% 94.37%
Interest Expense $966.8K $1.317M
YoY Change 16862.19% 30164.8%
% of Operating Profit
Other Income/Expense, Net -$316.3K $0.00
YoY Change
Pretax Income -$9.660M -$19.14M -$42.05M
YoY Change 14.0% 202.81% 96.19%
Income Tax $0.00 -$1.200M
% Of Pretax Income
Net Earnings -$9.660M -$19.14M -$40.85M
YoY Change 14.0% 202.81% 141.48%
Net Earnings / Revenue
Basic Earnings Per Share -$0.32 -$1.43
Diluted Earnings Per Share -$0.32 -$0.66 -$1.43
COMMON SHARES
Basic Shares Outstanding 30.72M 28.51M 28.60M
Diluted Shares Outstanding 30.43M 28.60M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $65.20M $73.82M $73.82M
YoY Change 10.73% 13.15% 13.15%
Cash & Equivalents $65.20M $73.80M $73.82M
Short-Term Investments
Other Short-Term Assets $2.774M $2.660M $2.660M
YoY Change 49.99% 66.52% 66.52%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $67.97M $76.48M $76.48M
YoY Change 11.93% 14.42% 14.42%
LONG-TERM ASSETS
Property, Plant & Equipment $148.3K $0.00 $527.5K
YoY Change -51.89% -100.0% 47.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $475.3K $527.5K $527.5K
YoY Change 54.14% 47.48% 47.48%
TOTAL ASSETS
Total Short-Term Assets $67.97M $76.48M $76.48M
Total Long-Term Assets $475.3K $527.5K $527.5K
Total Assets $68.45M $77.01M $77.01M
YoY Change 12.14% 14.6% 14.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.072M $1.219M $1.219M
YoY Change -24.53% -6.88% -6.88%
Accrued Expenses $1.858M $8.314M $8.545M
YoY Change -18.23% 280.02% 249.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $52.11K $56.61K $56.61K
YoY Change
Total Short-Term Liabilities $4.130M $9.821M $9.821M
YoY Change -17.71% 161.47% 161.47%
LONG-TERM LIABILITIES
Long-Term Debt $23.31M $23.18M $23.18M
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $23.31M $23.18M $23.18M
YoY Change 15758.03% 9918.09% 9918.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.130M $9.821M $9.821M
Total Long-Term Liabilities $23.31M $23.18M $23.18M
Total Liabilities $27.44M $33.01M $33.01M
YoY Change 431.17% 727.74% 727.74%
SHAREHOLDERS EQUITY
Retained Earnings -$111.2M -$101.6M
YoY Change 67.3%
Common Stock $10.14K $9.956K
YoY Change 6.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.01M $44.00M $44.00M
YoY Change
Total Liabilities & Shareholders Equity $68.45M $77.01M $77.01M
YoY Change 12.14% 14.6% 14.6%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$9.660M -$19.14M -$40.85M
YoY Change 14.0% 202.81% 141.48%
Depreciation, Depletion And Amortization $3.155K $11.58K $86.00
YoY Change 3405.56% 1118.95% -98.39%
Cash From Operating Activities -$13.19M -$7.529M -$25.71M
YoY Change 107.08% 67.26% 105.91%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.856M
YoY Change -79.7%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.568M 9.707M 34.29M
YoY Change 60886.05% 97066400.04% -29.87%
NET CHANGE
Cash From Operating Activities -13.19M -7.529M -25.71M
Cash From Investing Activities
Cash From Financing Activities 4.568M 9.707M 34.29M
Net Change In Cash -8.621M 2.178M 8.578M
YoY Change 35.51% -148.38% -76.44%
FREE CASH FLOW
Cash From Operating Activities -$13.19M -$7.529M -$25.71M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65242622
CY2021Q4 us-gaap Assets Current
AssetsCurrent
66840191
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86
CY2022 us-gaap Operating Expenses
OperatingExpenses
41672421
CY2021Q4 us-gaap Assets
Assets
67197888
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1309403
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
231430
CY2021Q4 us-gaap Liabilities
Liabilities
3987461
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00033
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00033
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30170317
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28448612
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28448612
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
9387
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
123904602
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60703562
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
63210427
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67197888
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29431027
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11254538
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12241394
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10184773
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-21439311
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42053760
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21434965
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1198905
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-40854855
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16918477
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-16918477
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28599221
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28599221
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25597125
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25597125
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-40854855
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-16918477
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
5196156
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4074458
CY2022 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
0
CY2021 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
35747
CY2022 us-gaap Depreciation
Depreciation
86
CY2021 us-gaap Depreciation
Depreciation
5357
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
241029
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
241031
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1062661
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
99904
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-90116
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-105821
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-294988
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-170839
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
344125
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9856116
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
48544998
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34287244
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48889123
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8577538
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
36403057
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65242622
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28839565
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73820160
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65242622
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001472091
CY2022 dei Auditor Firm
AuditorFirmId
185
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-37568
CY2022 dei Entity Registrant Name
EntityRegistrantName
PDS Biotechnology Corp
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4231384
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
25B Vreeland Road
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Florham Park
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07932
CY2022 dei City Area Code
CityAreaCode
800
CY2022 dei Local Phone Number
LocalPhoneNumber
208-3343
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.00033 per share
CY2022 dei Trading Symbol
TradingSymbol
PDSB
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
98323054
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30723610
CY2022 dei Auditor Name
AuditorName
KPMG LLP
CY2022 dei Auditor Location
AuditorLocation
Short Hills, New Jersey
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73820160
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2660230
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1597569
CY2022Q4 us-gaap Assets Current
AssetsCurrent
76480390
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
374888
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
152645
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
357611
CY2022Q4 us-gaap Assets
Assets
77007923
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1219287
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8313708
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2187704
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
56612
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
231429
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
258924
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9821036
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3756031
CY2022Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
23020844
CY2021Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
0
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
164013
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q4 us-gaap Liabilities
Liabilities
33005893
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30170317
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9956
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
145550491
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101558417
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
44002030
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77007923
CY2021 us-gaap Operating Expenses
OperatingExpenses
21439311
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-41672421
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
935180
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
4346
CY2022 us-gaap Interest Expense
InterestExpense
1316519
CY2021 us-gaap Interest Expense
InterestExpense
0
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-381339
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4346
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4516488
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40854855
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
27129576
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
257622
CY2021Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
35747
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3048618
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
24374327
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
441598
CY2021Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
220603
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48544998
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-588931
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
72992594
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1701763
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
123507
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6960966
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
67856898
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1673475
CY2021Q4 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
16
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-6319962
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
63210427
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
63210427
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1128973
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7488
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8473522
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
55873366
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1348601
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
22429
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5819200
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
51425196
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1344349
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1713741
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7424450
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
47058836
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1374233
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1563845
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1713305
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4999988
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9856116
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-19137683
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
44002030
CY2022 pdsb Issuance Of Shares In Licensing Agreement
IssuanceOfSharesInLicensingAgreement
4999988
CY2021 pdsb Issuance Of Shares In Licensing Agreement
IssuanceOfSharesInLicensingAgreement
0
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
183914
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
48992
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0
CY2022 pdsb Increase Decrease In Finance Lease Right To Use Asset
IncreaseDecreaseInFinanceLeaseRightToUseAsset
423880
CY2021 pdsb Increase Decrease In Finance Lease Right To Use Asset
IncreaseDecreaseInFinanceLeaseRightToUseAsset
0
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6126004
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
452382
CY2022 pdsb Increase Decrease In Finance Lease Liabilities
IncreaseDecreaseInFinanceLeaseLiabilities
220625
CY2021 pdsb Increase Decrease In Finance Lease Liabilities
IncreaseDecreaseInFinanceLeaseLiabilities
0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25709706
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12486066
CY2022 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
25000000
CY2021 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
449329
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
151416
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
270959
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2022 us-gaap Interest Paid Net
InterestPaidNet
852221
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 pdsb Fair Value Of Warrants Issued In Connection With Debt
FairValueOfWarrantsIssuedInConnectionWithDebt
1713741
CY2021 pdsb Fair Value Of Warrants Issued In Connection With Debt
FairValueOfWarrantsIssuedInConnectionWithDebt
0
CY2022Q4 pdsb Number Of Application Methods Of Use
NumberOfApplicationMethodsOfUse
2
CY2022Q4 pdsb Number Of Application Methods Of Use
NumberOfApplicationMethodsOfUse
2
CY2022Q4 pdsb License Agreement Up Front Cash Payment
LicenseAgreementUpFrontCashPayment
5000000
CY2022Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
378787
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000000
CY2022 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2022 pdsb License Agreement Up Front Cash Payment
LicenseAgreementUpFrontCashPayment
5000000
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4677540
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3361353
CY2022Q3 pdsb Commission Percentage
CommissionPercentage
0.03
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1238491
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9900000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73800000
CY2021Q2 pdsb Proceeds From Sale Of Unused Net Operating Loss Carryforwards
ProceedsFromSaleOfUnusedNetOperatingLossCarryforwards
4500000
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6088235
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
8.5
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
51700000
CY2021Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
48500000
CY2022Q4 pdsb Shelf Securities Available For Sale
ShelfSecuritiesAvailableForSale
29300000
CY2022Q2 pdsb Proceeds From Sale Of Unused Net Operating Loss Carryforwards
ProceedsFromSaleOfUnusedNetOperatingLossCarryforwards
1200000
CY2022Q3 pdsb Shelf Registration Statement Available For Future Sale
ShelfRegistrationStatementAvailableForFutureSale
150000000
CY2022Q3 pdsb Placement Shares Available For Future Sale
PlacementSharesAvailableForFutureSale
50000000
CY2022Q3 pdsb Placement Shares Available For Future Sale
PlacementSharesAvailableForFutureSale
50000000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
73820160
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
65242622
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
115420
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
115420
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
115420
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
115334
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86
CY2022 us-gaap Depreciation
Depreciation
86
CY2021 us-gaap Depreciation
Depreciation
5357
CY2022Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
11200
CY2022Q4 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P40M
CY2022Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P8M
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
700000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
700000
CY2020Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0915
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
294987
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
170839
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
241029
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
239470
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
0
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0
CY2022Q4 pdsb Lessee Operating Lease Liability To Be Paid Year Five And Thereafter
LesseeOperatingLeaseLiabilityToBePaidYearFiveAndThereafter
0
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
239470
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8041
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
231429
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
423880
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
74096
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
65432
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
65432
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
35690
CY2022Q4 pdsb Finance Lease Liability To Be Paid Year Five And Thereafter
FinanceLeaseLiabilityToBePaidYearFiveAndThereafter
22305
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
262955
CY2022Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
42330
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
220625
CY2022 pdsb Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
4
CY2022 pdsb Finance Lease Cost
FinanceLeaseCost
423880
CY2022Q4 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0915
CY2022 pdsb Lessee Finance Lease Monthly Rental Expense
LesseeFinanceLeaseMonthlyRentalExpense
5452
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
48992
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0
CY2022Q4 pdsb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
5645737
CY2021Q4 pdsb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
227400
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
550259
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
485400
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1837330
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1458310
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
280382
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
0
CY2021Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
16594
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8313708
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2187704
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5196156
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4074457
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9963
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0053
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0179
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0049
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M20D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y21D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.4
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.65
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q4 pdsb Number Of Votes For Each Share Of Common Stock
NumberOfVotesForEachShareOfCommonStock
1
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.048
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.13
CY2022 pdsb Effective Income Tax Rate Reconciliation Extraordinary Gain Percent
EffectiveIncomeTaxRateReconciliationExtraordinaryGainPercent
0
CY2021 pdsb Effective Income Tax Rate Reconciliation Extraordinary Gain Percent
EffectiveIncomeTaxRateReconciliationExtraordinaryGainPercent
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.004
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.089
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.029
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.028
CY2022 pdsb Effective Income Tax Rate Reconciliation Sale Of Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationSaleOfNetOperatingLossPercent
0.029
CY2021 pdsb Effective Income Tax Rate Reconciliation Sale Of Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationSaleOfNetOperatingLossPercent
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.283
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.018
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.029
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.211
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
25063210
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
22831097
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3166596
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3426561
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2696879
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1374830
CY2022Q4 pdsb Deferred Tax Assets Capitalization Of Research And Development Expenses
DeferredTaxAssetsCapitalizationOfResearchAndDevelopmentExpenses
4506729
CY2021Q4 pdsb Deferred Tax Assets Capitalization Of Research And Development Expenses
DeferredTaxAssetsCapitalizationOfResearchAndDevelopmentExpenses
0
CY2022Q4 pdsb Deferred Tax Assets License Agreement
DeferredTaxAssetsLicenseAgreement
2811000
CY2021Q4 pdsb Deferred Tax Assets License Agreement
DeferredTaxAssetsLicenseAgreement
0
CY2022Q4 pdsb Deferred Tax Assets Amortization Of Patents
DeferredTaxAssetsAmortizationOfPatents
29463
CY2021Q4 pdsb Deferred Tax Assets Amortization Of Patents
DeferredTaxAssetsAmortizationOfPatents
35579
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
0
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
4665
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
732064
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
719666
CY2022Q4 pdsb Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
127278
CY2021Q4 pdsb Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
137838
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
15278
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
15278
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
42553261
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30616841
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
42404971
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30516318
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
148290
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
100523
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
148290
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
100523
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
148290
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
100523
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
42400000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30500000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
11900000
CY2022Q4 pdsb Deferred Tax Assets Capitalization Of Research And Development Expenses
DeferredTaxAssetsCapitalizationOfResearchAndDevelopmentExpenses
4500000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1200000
CY2022Q4 pdsb Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
232500
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
185195
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
381625
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.6685
CY2022Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
449329
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2916655
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
1288776
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
183914
CY2021Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
35747
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
157009
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
60428

Files In Submission

Name View Source Status
0001140361-23-014279-index-headers.html Edgar Link pending
0001140361-23-014279-index.html Edgar Link pending
0001140361-23-014279.txt Edgar Link pending
0001140361-23-014279-xbrl.zip Edgar Link pending
brhc10050281_10k.htm Edgar Link pending
brhc10050281_ex10-9.htm Edgar Link pending
brhc10050281_ex21-1.htm Edgar Link pending
brhc10050281_ex23-1.htm Edgar Link pending
brhc10050281_ex31-1.htm Edgar Link pending
brhc10050281_ex31-2.htm Edgar Link pending
brhc10050281_ex32-1.htm Edgar Link pending
brhc10050281_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image00001.jpg Edgar Link pending
image00014.jpg Edgar Link pending
image00015.jpg Edgar Link pending
image00016.jpg Edgar Link pending
image00017.jpg Edgar Link pending
image00018.jpg Edgar Link pending
image00019.jpg Edgar Link pending
image00020.jpg Edgar Link pending
image00021.jpg Edgar Link pending
image00022.jpg Edgar Link pending
image00023.jpg Edgar Link pending
image00024.jpg Edgar Link pending
image00025.jpg Edgar Link pending
image00026.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pdsb-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
pdsb-20221231_def.xml Edgar Link unprocessable
pdsb-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pdsb-20221231_pre.xml Edgar Link unprocessable
brhc10050281_10k_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pdsb-20221231_cal.xml Edgar Link unprocessable